Serum KL-6 is significantly correlated with computed tomography score and can help us to assess disease severity in COVID-19, which might be because SARS-CoV-2 mainly damages AT-II cells through ACE2 [36, 37, 38, 39]. This evidence concerns the gene ACE2 and COVID-19.